| Product Code: ETC10765566 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Austria`s import trend for pemetrexed saw a steady increase, driven by rising demand for this cancer treatment drug. Imports of pemetrexed into Austria surged, reflecting the country`s reliance on foreign sources to meet domestic needs in the pharmaceutical sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Pemetrexed Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Pemetrexed Market Revenues & Volume, 2022 & 2032F |
3.3 Austria Pemetrexed Market - Industry Life Cycle |
3.4 Austria Pemetrexed Market - Porter's Five Forces |
3.5 Austria Pemetrexed Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Austria Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2022 & 2032F |
3.7 Austria Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2022 & 2032F |
3.8 Austria Pemetrexed Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Austria Pemetrexed Market Revenues & Volume Share, By Administration Route, 2022 & 2032F |
4 Austria Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of lung cancer in Austria |
4.2.2 Growing awareness about the benefits of pemetrexed in cancer treatment |
4.2.3 Advancements in healthcare infrastructure and access to innovative therapies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 High cost associated with pemetrexed treatment |
4.3.3 Competition from alternative cancer treatment options |
5 Austria Pemetrexed Market Trends |
6 Austria Pemetrexed Market, By Types |
6.1 Austria Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Austria Pemetrexed Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Austria Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2022 - 2032F |
6.1.4 Austria Pemetrexed Market Revenues & Volume, By Mesothelioma, 2022 - 2032F |
6.1.5 Austria Pemetrexed Market Revenues & Volume, By Breast Cancer, 2022 - 2032F |
6.1.6 Austria Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2022 - 2032F |
6.1.7 Austria Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2022 - 2032F |
6.2 Austria Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Austria Pemetrexed Market Revenues & Volume, By Antifolate, 2022 - 2032F |
6.2.3 Austria Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2022 - 2032F |
6.2.4 Austria Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2022 - 2032F |
6.2.5 Austria Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2022 - 2032F |
6.2.6 Austria Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2022 - 2032F |
6.3 Austria Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Austria Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2022 - 2032F |
6.3.3 Austria Pemetrexed Market Revenues & Volume, By Immunotherapy, 2022 - 2032F |
6.3.4 Austria Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2022 - 2032F |
6.3.5 Austria Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2022 - 2032F |
6.3.6 Austria Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.4 Austria Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Austria Pemetrexed Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Austria Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2022 - 2032F |
6.4.4 Austria Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.5 Austria Pemetrexed Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4.6 Austria Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.5 Austria Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Austria Pemetrexed Market Revenues & Volume, By Intravenous, 2022 - 2032F |
6.5.3 Austria Pemetrexed Market Revenues & Volume, By Injection, 2022 - 2032F |
6.5.4 Austria Pemetrexed Market Revenues & Volume, By IV Infusion, 2022 - 2032F |
6.5.5 Austria Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2022 - 2032F |
6.5.6 Austria Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
7 Austria Pemetrexed Market Import-Export Trade Statistics |
7.1 Austria Pemetrexed Market Export to Major Countries |
7.2 Austria Pemetrexed Market Imports from Major Countries |
8 Austria Pemetrexed Market Key Performance Indicators |
8.1 Patient survival rates post-pemetrexed treatment |
8.2 Adoption rate of pemetrexed in cancer treatment protocols |
8.3 Number of research studies and clinical trials involving pemetrexed |
9 Austria Pemetrexed Market - Opportunity Assessment |
9.1 Austria Pemetrexed Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Austria Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2022 & 2032F |
9.3 Austria Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2022 & 2032F |
9.4 Austria Pemetrexed Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Austria Pemetrexed Market Opportunity Assessment, By Administration Route, 2022 & 2032F |
10 Austria Pemetrexed Market - Competitive Landscape |
10.1 Austria Pemetrexed Market Revenue Share, By Companies, 2025 |
10.2 Austria Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here